Trial supplies of candidate breast cancer radio-mAb still stable after 5 years says study 11-Sep-2015 By Gareth Macdonald Trial supplies of a radio-immunotherapy drug made by Areva Med in compliance with GMP are stable five years after they were produced according to the results of new analysis.